CARE vs NKSH

For growth investors, National Bankshares, Inc.

(NKSH) is the stronger pick with 7. 9% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). National Bankshares, Inc. (NKSH) offers the better valuation at 14. 7x trailing P/E (11. 4x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, National Bankshares, Inc.

(NKSH) is the cheapest at 14. 7x versus Carter Bankshares, Inc. at 18. 7x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Carter Bankshares, Inc.

(CARE) delivered a total return of +88. 0%, compared to +28. 3% for National Bankshares, Inc. (NKSH). Over 10 years, the gap is even starker: CARE returned +111. 1% versus NKSH's +50. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Carter Bankshares, Inc.

(CARE) is the lower-risk stock at 0. 56β versus National Bankshares, Inc. 's 0. 76β — meaning NKSH is approximately 34% more volatile than CARE relative to the S&P 500. On balance sheet safety, National Bankshares, Inc. (NKSH) carries a lower debt/equity ratio of 1% versus 43% for Carter Bankshares, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), National Bankshares, Inc.

(NKSH) is pulling ahead at 7. 9% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: National Bankshares, Inc. grew EPS 100. 8% year-over-year, compared to 32. 1% for Carter Bankshares, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

National Bankshares, Inc.

(NKSH) is the more profitable company, earning 18. 6% net margin versus 12. 3% for Carter Bankshares, Inc. — meaning it keeps 18. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NKSH leads at 22. 5% versus 15. 7% for CARE. At the gross margin level — before operating expenses — NKSH leads at 65. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Carter Bankshares, Inc.

(CARE) trades at 4. 8x forward P/E versus 11. 4x for National Bankshares, Inc. — 6. 6x cheaper on a one-year earnings basis.

In this comparison, NKSH (4.

1% yield) pays a dividend. CARE does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, National Bankshares, Inc.

(NKSH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 76), 4. 1% yield). Both have compounded well over 10 years (NKSH: +50. 4%, CARE: +111. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CARE is a small-cap quality compounder stock; NKSH is a small-cap deep-value stock. NKSH pays a dividend while CARE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.